Abstract
Purpose of Review: To provide an update on stroke prevention strategies with oral anticoagulants (vitamin K antagonists) and platelet inhibitors. Recent Findings: In asymptomatic women, aspirin reduces the risk of stroke but not of myocardial infarction while in men only the risk of myocardial infarction but not stroke could be significantly reduced. No benefit of oral anticoagulants could be shown in patients with non-cardioembolic stroke. Patients with symptomatic intracranial stenosis had a higher risk of intracerebral bleeding with oral anticoagulation compared to high dose aspirin. The combination of aspirin plus extended-release dipyridamole significantly reduces the risk of recurrent stroke as well as the risk of a combined cardiovascular outcome compared to aspirin alone. The combination of aspirin plus clopidogrel did not reduce the risk of stroke in patients with non-cardioembolic ischemic events compared to clopidogrel monotherapy. Summary: For primary prevention in patients < 65 years without risk factors, no antithrombotic treatment should be given. The choice between oral anticoagulants and antiplatelet agents depends on the stroke etiology and individual risk factor profile. Patients with non-cardioembolic stroke generally are candidates for antiplatelet therapy. New anticoagulation strategies will facilitate dosing and may reduce under-use in patients with atrial fibrillation and clear indications for oral anticoagulation.
Keywords: Stroke, prevention, recurrence, anticoagulation, antiplatelet therapy
Current Drug Therapy
Title: Antiplatelet Therapy and Oral Anticoagulation for Prevention of Ischemic Stroke
Volume: 1 Issue: 3
Author(s): Christian Weimar and Hans-Christoph Diener
Affiliation:
Keywords: Stroke, prevention, recurrence, anticoagulation, antiplatelet therapy
Abstract: Purpose of Review: To provide an update on stroke prevention strategies with oral anticoagulants (vitamin K antagonists) and platelet inhibitors. Recent Findings: In asymptomatic women, aspirin reduces the risk of stroke but not of myocardial infarction while in men only the risk of myocardial infarction but not stroke could be significantly reduced. No benefit of oral anticoagulants could be shown in patients with non-cardioembolic stroke. Patients with symptomatic intracranial stenosis had a higher risk of intracerebral bleeding with oral anticoagulation compared to high dose aspirin. The combination of aspirin plus extended-release dipyridamole significantly reduces the risk of recurrent stroke as well as the risk of a combined cardiovascular outcome compared to aspirin alone. The combination of aspirin plus clopidogrel did not reduce the risk of stroke in patients with non-cardioembolic ischemic events compared to clopidogrel monotherapy. Summary: For primary prevention in patients < 65 years without risk factors, no antithrombotic treatment should be given. The choice between oral anticoagulants and antiplatelet agents depends on the stroke etiology and individual risk factor profile. Patients with non-cardioembolic stroke generally are candidates for antiplatelet therapy. New anticoagulation strategies will facilitate dosing and may reduce under-use in patients with atrial fibrillation and clear indications for oral anticoagulation.
Export Options
About this article
Cite this article as:
Weimar Christian and Diener Hans-Christoph, Antiplatelet Therapy and Oral Anticoagulation for Prevention of Ischemic Stroke, Current Drug Therapy 2006; 1 (3) . https://dx.doi.org/10.2174/157488506778194965
DOI https://dx.doi.org/10.2174/157488506778194965 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Current Pharmaceutical Design Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets New Horizons in Diabetes Therapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Current Vascular Pharmacology Recent Advances in Developing K-Ras Plasma Membrane Localization Inhibitors
Current Topics in Medicinal Chemistry Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases
Current Topics in Medicinal Chemistry Targeting Established Tumor Vasculature: A Novel Approach to Cancer Treatment
Current Cancer Therapy Reviews Aging is Not a Disorder
Current Aging Science T-Cell-Mediated Signalling in Immune, Inflammatory and Angiogenic Processes: The Cascade of Events Leading to Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy Effects of Creatine in Skeletal Muscle Cells and in Myoblasts Differentiating Under Normal or Oxidatively Stressing Conditions
Mini-Reviews in Medicinal Chemistry Reductions in Medications with Substantial Weight Loss with Behavioral Intervention
Current Clinical Pharmacology Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design The Prevalence of Frailty in Patients Admitted to Hospital with Vertebral Fragility Fractures
Current Rheumatology Reviews L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?
Letters in Drug Design & Discovery Novel approaches to examine the regulation of voltage-gated calcium channels in the heart
Current Molecular Pharmacology Drug Metabolizing Enzymes and Transporters mRNA in Peripheral Blood Mononuclear Cells of Healthy Subjects: Biological Variations and Importance of Preanalytical Steps
Current Drug Metabolism Antipsychotic-Induced Electrocardiographic Changes: A Comparative Study Between Olanzapine and Risperidone
Current Psychopharmacology Multi-target Activities of Selected Alkaloids and Terpenoids
Mini-Reviews in Organic Chemistry Vascular, Oxidative, and Synaptosomal Abnormalities During Aging and the Progression of Type 2 Diabetes
Current Neurovascular Research